In this week’s Video Forum, Joe DePinto, head of cell, gene and advanced therapies at McKesson, talks about the company’s new InspiroGene division and the impact it is expected to have on the biotech marketplace. Precision dispensing and patient management, the product pipeline for advanced therapies, and recent research from InspiroGene were among the topics discussed.
Video Forum: Joe DePinto, McKesson
New division takes aim at cell and gene therapies.
Latest
retailmediaIQ offices to close for Labor Day
We wish our readers, partners and colleagues a safe and enjoyable holiday weekend.
GOODLES is acquired by Barilla Group
GOODLES will remain independent, continuing its daring reimagination of boxed mac and cheese
Natural Grocers launches nationwide delivery with DoorDash
The partnership brings on-demand and scheduled delivery to all 174 Natural Grocers stores nationwide.